229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-5.48%
Negative revenue growth while VUZI stands at 26.83%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-6.13%
Negative gross profit growth while VUZI is at 22.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-9.13%
Negative EBIT growth while VUZI is at 77.17%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-9.13%
Negative operating income growth while VUZI is at 77.17%. Joel Greenblatt would press for urgent turnaround measures.
-9.26%
Negative net income growth while VUZI stands at 77.29%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-8.50%
Negative EPS growth while VUZI is at 77.42%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-8.50%
Negative diluted EPS growth while VUZI is at 77.42%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.56%
Share reduction while VUZI is at 3.08%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.75%
Reduced diluted shares while VUZI is at 3.08%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
5.57%
Dividend growth of 5.57% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
27.18%
OCF growth above 1.5x VUZI's 6.36%. David Dodd would confirm a clear edge in underlying cash generation.
29.06%
FCF growth 75-90% of VUZI's 36.98%. Bill Ackman might push for improved capital allocation or operational changes to match the competitor.
259.74%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
90.24%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
14.34%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
341.77%
10Y OCF/share CAGR above 1.5x VUZI's 40.12%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
195.96%
5Y OCF/share CAGR above 1.5x VUZI's 59.73%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
48.50%
3Y OCF/share CAGR above 1.5x VUZI's 17.28%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
334.57%
Net income/share CAGR above 1.5x VUZI's 56.53% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
154.83%
5Y net income/share CAGR above 1.5x VUZI's 18.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
7.07%
Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.
-13.41%
Negative equity/share CAGR over 10 years while VUZI stands at 161.71%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-17.47%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
12.65%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
113.28%
Dividend/share CAGR of 113.28% while VUZI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
28.08%
Dividend/share CAGR of 28.08% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
12.24%
3Y dividend/share CAGR of 12.24% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
4.91%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-1.08%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-1.72%
Negative asset growth while VUZI invests at 9.45%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-9.59%
We have a declining book value while VUZI shows 8.37%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-3.14%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
1.30%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
-2.29%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
